| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.007 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.0068 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |